Research ArticleResearch Article

Gemcitabine and Docetaxel as a Second-Line Treatment in Advanced Soft Tissue Sarcomas

Hend Ahmed El-Hadaad and Hanan AHMED WAHBA
Clinical Oncology and Cancer Research September 2011, 8 (3) 133-137; DOI: https://doi.org/10.1007/s11805-011-0571-y

Article Information

vol. 8 no. 3 133-137
DOI 
https://doi.org/10.1007/s11805-011-0571-y
Published By 
Cancer Biology & Medicine
History 
  • Received May 19, 2011
  • Accepted August 3, 2011
  • Published online September 1, 2011.
Copyright & Usage 
Copyright © 2011 by Tianjin Medical University Cancer Institute & Hospital and Springer

Author Information

  1. Hend Ahmed El-Hadaad⇑
  1. Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  1. Correspondence to: Hend Ahmed El-Hadaad Tel: 20-50-2227981 Fax: 20-50-2249934 E-mail: hend_am{at}mans.edu.eg
  1. Hanan AHMED WAHBA
  1. Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
View Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords